Bone Biologics Corp Warrants (BBLGW)

About BBLGW

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine impla…

Sector

Health Care

Industry

Industrial Specialties

Employees

2

Website

www.bonebiologics.com

Fundamentals

1-day range

$7.05$7.76

Market cap

$14.48M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.14

Dividend yield

—

Beta

0.53

Avg. volume

427

Bone Biologics Corp Warrants Competitors

Chosen by industry and closest market cap.

• BBLGW

  Bone Biologics Corp Warrants

  $5.7

  ▼ 25.49%
  Market cap $14.48MP/E —
  $3.5$35.95
• FGI

  FGI Industries Ltd. Ordinary Shares

  $7.37

  ▼ 1.60%
  Market cap $8.30MP/E —
  $3.14$19.93
• CLGN

  CollPlant Biotechnologies Ltd Ordinary Shares

  $0.345

  ▲ 18.97%
  Market cap $6.01MP/E —
  $0.2637$3.18
• FEED

  ENvue Medical Inc. Common Stock

  $0.3366

  ▼ 8.53%
  Market cap $3.19MP/E —
  $0.29$17.4
• NTRBW

  Nutriband Inc. Warrant

  $0.45

  ▼ 35.71%
  Market cap $3.04MP/E —
  $0.25$2.99
• NTRB

  Nutriband Inc. Common Stock

  $4.51

  ▼ 2.49%
  Market cap $34.16MP/E —
  $2.8$8.63
• MYO

  Myomo Inc. Common Stock

  $1.61

  ▼ 3.31%
  Market cap $40.18MP/E —
  $0.605$1.89

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

30.2K

Total value held

$689.9K

Institutional holders

2